Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    LEARN HOW THE U.S. FDA REGULATES VETERINARY MEDICA 2015 - Veterinary Medical Devices and FDA Regulatory Oversight

    View: 234

    Website http://bit.ly/1t4rMNo | Want to Edit it Edit Freely

    Category FDA GXP Compliance - Medical Devices

    Deadline: January 27, 2015 | Date: January 27, 2015

    Venue/Country: Palo Alto, U.S.A

    Updated: 2015-01-23 14:24:19 (GMT+9)

    Call For Papers - CFP

    This course will discuss the regulatory requirements for marketing and selling veterinary medical devices in the U.S. Attendees will learn how to adhere to the safety standard applicable to a device and how to appropriately label a veterinary medical device to comply with FDA requirements.

    Why Should You Attend:

    The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) has regulatory jurisdiction over veterinary medical devices and has shown little interest in the market sector based on the existence of historical enforcement action. However, with the growing marketing and promotion of injectable devices for horses and dogs, it is possible that such enforcement discretion may be abandoned for greater regulatory scrutiny and oversight.

    Who Will Benefit:

    This course is designed for individuals tasked with developing and maintaining an animal health company’s product portfolio that includes veterinary medical devices; and those responsible for overseeing a company’s regulatory strategies and mitigating possible FDA enforcement risk. This includes:

    Division Directors and Chiefs

    Business Development Team Members

    Senior Quality Managers

    Quality Professionals

    Legal and Regulatory Professionals

    Compliance Professionals

    Labelers and Private Labelers

    Contract Manufacturers

    Instructor Profile:

    Karl M. Nobert focuses his practice on the representation and counseling of clients in the food and drug industry including advising clients on matters related to the regulation of human prescription and nonprescription drugs, human and veterinary biological products including regenerative medicine, medical devices, food and dietary supplements. Mr. Nobert also assists clients with the preparation of FDA submissions including human and veterinary new drug and generic drug applications; 510(k) premarket notifications, premarket approval applications, recalls and market withdrawals, GRAS self-affirmations and notifications, and product listings and establishment registrations.


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.